Publication | Open Access

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone

Drug InteractionsHiv-negative SubjectsPharmacokinetic InteractionsTreatment And PreventionPharmacologyAntiviral TherapyPharmacotherapyAntiviral DrugHivMedicinePharmacokineticsDrug Resistance